OVIT (OncoVista Innovative Therapies) YoY EBITDA Growth: -227.27% (As of Sep. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OncoVista Innovative Therapies YoY EBITDA Growth?

OncoVista Innovative Therapies OVIT YoY EBITDA Growth is -227.27% as of Sep. 2015.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. OncoVista Innovative Therapies's YoY EBITDA Growth for the quarter that ended in Sep. 2015 was -227.27%.

OncoVista Innovative Therapies's EBITDA per Share for the three months ended in Sep. 2015 was $-0.01.

OncoVista Innovative Therapies YoY EBITDA Growth Related Terms

OncoVista Innovative Therapies YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies YoY EBITDA Growth Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.07 11.97 27.18 6.67 -68.57

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 164.71 -247.62 14.29 -19.51 -227.27

OncoVista Innovative Therapies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

OncoVista Innovative Therapies's YoY EBITDA Growth for the fiscal year that ended in Dec. 2014 is calculated as:

YoY EBITDA Growth (A: Dec. 2014 )
=(EBITDA per Share (A: Dec. 2014 )-EBITDA per Share (A: Dec. 2013 ))/ | EBITDA per Share (A: Dec. 2013 ) |
=(-0.118--0.07)/ | -0.07 |
=-68.57 %

OncoVista Innovative Therapies's YoY EBITDA Growth for the quarter that ended in Sep. 2015 is calculated as:

YoY EBITDA Growth (Q: Sep. 2015 )
=(EBITDA per Share (Q: Sep. 2015 )-EBITDA per Share (Q: Sep. 2014 )) / | EBITDA per Share (Q: Sep. 2014 )) |
=(-0.014-0.011)/ | 0.011 |
=-227.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -227.27% mean?
OncoVista Innovative Therapies (OVIT) has a YoY EBITDA Growth of -227.27% as of Sep. 2015. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' YoY EBITDA Growth too high?
OncoVista Innovative Therapies' current YoY EBITDA Growth is -227.27%.
How does OncoVista Innovative Therapies' YoY EBITDA Growth compare to RSPI and HSTC?
OncoVista Innovative Therapies' YoY EBITDA Growth of -227.27% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Biotechnology company?
A good YoY EBITDA Growth depends on the Biotechnology industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current YoY EBITDA Growth is -227.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current YoY EBITDA Growth of -227.27%. The current YoY EBITDA Growth is -227.27%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current YoY EBITDA Growth is -227.27% as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.